CA3280572A1 - Composés deutérés - Google Patents

Composés deutérés

Info

Publication number
CA3280572A1
CA3280572A1 CA3280572A CA3280572A CA3280572A1 CA 3280572 A1 CA3280572 A1 CA 3280572A1 CA 3280572 A CA3280572 A CA 3280572A CA 3280572 A CA3280572 A CA 3280572A CA 3280572 A1 CA3280572 A1 CA 3280572A1
Authority
CA
Canada
Prior art keywords
deuterated compounds
deuterated
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3280572A
Other languages
English (en)
Inventor
Evan Smith
Giles Albert Brown
Miles Stuart Congreve
Original Assignee
Nxera Pharma UK Ltd
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nxera Pharma UK Ltd, Neurocrine Biosciences Inc filed Critical Nxera Pharma UK Ltd
Publication of CA3280572A1 publication Critical patent/CA3280572A1/fr
Pending legal-status Critical Current

Links

CA3280572A 2023-01-24 2024-01-19 Composés deutérés Pending CA3280572A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/440,812 2023-01-24

Publications (1)

Publication Number Publication Date
CA3280572A1 true CA3280572A1 (fr) 2024-08-02

Family

ID=

Similar Documents

Publication Publication Date Title
HK40130368A (en) Deuterated compounds
HK40118460A (en) Deuterated compounds
CA3310209A1 (fr) Composes de pyrazolopiperazine
CA3305167A1 (fr) Composés ciblant la survivine
CA3295507A1 (fr) Composés
CA3295511A1 (en) Compounds
CA3283976A1 (fr) Composés
AU2023903954A0 (en) Compounds
CA3275025A1 (fr) Composés
AU2023902053A0 (en) Compounds
AU2023902054A0 (en) Compounds
CN309487499S (en) Case
AU2023900353A0 (en) Compounds
CA3305044A1 (fr) Nouveaux composés
AU2022904012A0 (en) Compounds
CA3300951A1 (fr) Dérivés de pyridine agissant en tant qu'inhibiteurs de mptp
CA3273747A1 (fr) Nouveaux composés anti-sénescence
AU2023902838A0 (en) Novel Compounds
AU2022901974A0 (en) Anti-Giardial Compounds
HK40128852A (en) Novel compounds
GB202201331D0 (en) Deuterated compounds
AU2022901458A0 (en) Compounds
AU2022902514A0 (en) Novel Compounds
EP4089095A4 (fr) Composé thiénopyridine deutéré
CA3268342A1 (fr) Composé de triphénylazole